Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.

DNA Damage can Stall the Cell Cycle

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

DNA Damage Can Stall the Cell Cycle

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Molecular Factors Affecting Cell Division

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MDM2 suppresses c-Myc synthesis by binding to the 5' mRNA translation regulatory sequence.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Cancer-associated synonymous mutations reveal stress signal-dependent mRNA folding that selectively modulates protein function.

RNA (New York, N.Y.)·2026

Same author

Reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA.

Bioscience reports·2025

Same author

The <i>p53</i> mRNA exhibits riboswitch-like features under DNA damage conditions.

iScience·2025

Same author

The codon context provides <i>cis</i>-acting immune evasion for the human papilloma virus (HPV) E6.

RNA (New York, N.Y.)·2025

Same author

A cancer-associated TP53 synonymous mutation induces synthesis of the p53 isoform p53/47.

British journal of cancer·2025

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

P53 mRNA controls p53 activity by managing Mdm2 functions.

Marco M Candeias¹, Laurence Malbert-Colas, Darren J Powell

¹Inserm U716, Pharmacologie Expérimentale, Institut Génétique Moléculaire, Hôpital St Louis and Université Paris 7, 27 rue Juliette Dodu, 75010 Paris, France.

Nature Cell Biology

|January 23, 2009

Summary

The E3 ubiquitin ligase Mdm2 regulates tumor suppressor p53. Mdm2 binding to p53 mRNA enhances p53 translation and reduces degradation, with silent mutations impacting this regulation.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Experiment Videos

Last Updated: Jun 26, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Area of Science:

Molecular Biology
Cancer Research
Gene Regulation

Background:

Mdm2 (E3 ubiquitin ligase) is a key regulator of the p53 tumor suppressor.
Mdm2 controls p53 through both degradation and synthesis.
The precise mechanism for Mdm2's dual regulation of p53 synthesis and degradation remains unclear.

Purpose of the Study:

To elucidate the mechanism behind Mdm2's dual regulation of p53 synthesis and degradation.
To investigate the direct interaction between p53 mRNA and Mdm2.
To assess the impact of silent mutations in p53 mRNA on Mdm2 binding and p53 activity.

Main Methods:

RNA-protein interaction assays to study p53 mRNA and Mdm2 binding.
In vitro assays to assess E3 ligase activity.
Analysis of p53 mRNA translation and protein degradation.
Site-directed mutagenesis to introduce silent point mutations in p53 mRNA.

Main Results:

The p53 mRNA region encoding the Mdm2-binding site directly interacts with Mdm2's RING domain.
This interaction inhibits Mdm2's E3 ligase activity, thereby promoting p53 mRNA translation.
Cancer-derived silent point mutations in p53 mRNA weaken Mdm2 binding, leading to reduced p53 activity.

Conclusions:

Mdm2-mediated control of p53 synthesis and degradation is intrinsically linked to the p53 mRNA sequence.
Silent nucleotides within p53 mRNA can influence protein function by modulating Mdm2 interactions.
This highlights a novel layer of gene regulation where mRNA sequence elements dictate protein stability and synthesis.